Discovery of a Novel Dystrophin Isoform in the Heart

Student Researcher:
Quynh Nguyen

Supervisor / Principle Investigator:
Toshifumi Yokota

Additional Authors:
Kenji Rowel Q. Lim

MD Class of 2022

ABSTRACT

Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disease affecting 1 in 3500-5000 males. DMD is characterized by progressive muscle degeneration due to loss-of-function mutations in the dystrophin (DMD) gene coding for dystrophin, a cytoskeletal protein that stabilizes muscle cell membranes. Since dystrophin functions similarly in skeletal and cardiac muscles, DMD patients experience various degrees of cardiomyopathy besides skeletal muscle degeneration. To develop a new therapy for DMD, our group uses the canine X-linked muscular dystrophy Japan model (CXMDJ). These dogs harbor an acceptor site point mutation on DMD intron 6, causing exon 7 exclusion from the final mRNA which produces a premature stop codon. Interestingly when we performed Western blot on cardiac muscle from non-treated CXMDJ dogs, dystrophin bands of near full-length size were present at detectable levels. A previous study reported a patient with an out-of-frame exon 3-7 deletion, however, dystrophin-positive fibres were detected using antibody against exon 8. We hypothesized that the dystrophin isoform detected in non-treated dogs is the product of a new transcription start site (TSS) on exon 8 of the DMD gene. qPCR showed elevated expression of dystrophin past the putative TSS in left ventricle and transverse septum samples from dystrophic dogs. Immunohistochemistry confirmed that dystrophin-positive signals were specific to the endothelial layer of the blood vessels in the heart. Furthermore, these signals were observed when antibody against exon 8 after the putative TSS was used. Western blot using antibody against exon 8 after the putative TSS also showed bands of near full-length size dystrophin in cardiac muscle from dystrophic dogs. These data support our hypothesis of a novel heart-specific dystrophin isoform. Characterization of this new isoform will have important implications both for the treatment of DMD and our understanding of dystrophin’s regulation and biological roles in the heart.

 
 

Next